AKYA RSI Chart
Last 7 days
-32.9%
Last 30 days
-26.8%
Last 90 days
-52.0%
Trailing 12 Months
-52.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 93.6M | 0 | 0 | 0 |
2023 | 79.4M | 85.0M | 91.4M | 96.6M |
2022 | 59.6M | 64.4M | 69.8M | 74.9M |
2021 | 43.6M | 48.1M | 51.7M | 54.9M |
2020 | 0 | 0 | 0 | 42.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 01, 2024 | ek john frederick | sold (taxes) | -65,080 | 4.56 | -14,272 | cfo |
Mar 23, 2024 | ramachandran niro ph.d | sold (taxes) | -9,608 | 4.79 | -2,006 | chief business officer |
Mar 23, 2024 | mckelligon brian | sold (taxes) | -34,176 | 4.79 | -7,135 | president and ceo |
Mar 23, 2024 | pla frederic | sold (taxes) | -9,608 | 4.79 | -2,006 | chief operating officer |
Mar 20, 2024 | mckelligon brian | acquired | 2,272 | 0.303 | 7,500 | president and ceo |
Mar 20, 2024 | mckelligon brian | sold | -37,242 | 4.9657 | -7,500 | president and ceo |
Mar 13, 2024 | mckelligon brian | acquired | 2,272 | 0.303 | 7,500 | president and ceo |
Mar 13, 2024 | mckelligon brian | sold | -37,042 | 4.939 | -7,500 | president and ceo |
Mar 13, 2024 | mckelligon brian | sold | -37,035 | 4.938 | -7,500 | president and ceo |
Mar 13, 2024 | shepler robert g | gifted | - | - | 369,592 | - |
Which funds bought or sold AKYA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -39.07 | -44,636 | 63,066 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -38.92 | -7,690 | 10,932 | -% |
May 15, 2024 | Steward Partners Investment Advisory, LLC | unchanged | - | -76.00 | 1,876 | -% |
May 15, 2024 | Parkman Healthcare Partners LLC | added | 35.96 | 1,009,840 | 4,302,800 | 0.53% |
May 15, 2024 | Kent Lake Capital LLC | sold off | -100 | -570,155 | - | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -55.8 | -61,590 | 45,483 | -% |
May 15, 2024 | Blue Water Life Science Advisors, LP | unchanged | - | -892,579 | 22,032,600 | 20.72% |
May 15, 2024 | STEPHENS INC /AR/ | reduced | -28.26 | -26,340 | 58,489 | -% |
May 15, 2024 | Polar Capital Holdings Plc | unchanged | - | -300,153 | 7,409,060 | 0.04% |
May 15, 2024 | AMERIPRISE FINANCIAL INC | reduced | -12.93 | -31,876 | 163,446 | -% |
Unveiling Akoya Biosciences, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Akoya Biosciences, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Akoya Biosciences, Inc. News
Income Statement (Quarterly) | ||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 |
Revenue | -30.7% | 18,350,000 | 26,487,000 | 25,215,000 | 23,521,000 | 21,410,000 | 21,219,000 | 18,852,000 | 17,894,000 | 16,894,000 | 16,158,000 | 13,476,000 | 13,071,000 | 12,212,000 | 12,908,000 | 9,954,000 | 8,560,000 | 11,021,000 |
Cost Of Revenue | 1.1% | 9,971,000 | 9,867,000 | 9,939,000 | 11,405,000 | 9,117,000 | 9,173,000 | 7,945,000 | 7,553,000 | 6,798,000 | 5,932,000 | 5,023,000 | 4,937,000 | 4,807,000 | 5,000,000 | 3,920,000 | 3,290,000 | 4,325,000 |
Gross Profit | -49.6% | 8,379,000 | 16,620,000 | 15,276,000 | 12,116,000 | 12,293,000 | 12,046,000 | 10,907,000 | 10,341,000 | 10,096,000 | 10,226,000 | 8,453,000 | 8,134,000 | 7,405,000 | 7,908,000 | 6,034,000 | 5,270,000 | 6,696,000 |
Operating Expenses | 15.0% | 29,964,000 | 26,059,000 | 26,827,000 | 31,358,000 | 29,729,000 | 29,637,000 | 27,560,000 | 26,649,000 | 25,650,000 | 27,006,000 | 19,192,000 | 14,512,000 | 12,806,000 | 11,057,000 | 9,701,000 | 9,102,000 | 8,059,000 |
S&GA Expenses | 5.1% | 19,863,000 | 18,898,000 | 19,017,000 | 22,708,000 | 21,758,000 | 20,948,000 | 19,922,000 | 20,590,000 | 18,193,000 | 19,046,000 | 13,725,000 | 10,066,000 | 8,179,000 | 6,816,000 | 5,712,000 | 5,105,000 | 6,349,000 |
R&D Expenses | 18.9% | 5,554,000 | 4,670,000 | 5,173,000 | 6,273,000 | 5,773,000 | 6,433,000 | 5,466,000 | 5,598,000 | 5,714,000 | 5,563,000 | 3,999,000 | 2,947,000 | 3,192,000 | 2,532,000 | 2,279,000 | 2,420,000 | 2,372,000 |
EBITDA Margin | -12.4% | -0.55 | -0.49 | -0.62 | -0.74 | -0.77 | -0.81 | -0.86 | -0.85 | -0.73 | -0.65 | -0.46 | -0.35 | - | - | - | - | - |
Interest Expenses | 13.7% | 2,243,000 | 1,972,000 | 1,973,000 | 1,912,000 | 1,793,000 | 1,288,000 | 899,000 | 652,000 | 638,000 | 726,000 | 652,000 | 652,000 | 638,000 | 871,000 | 464,000 | 454,000 | 457,000 |
Income Taxes | 386.4% | 63,000 | -22,000 | 15,000 | 18,000 | 29,000 | -26,000 | 21,000 | 106,000 | 22,000 | -117,000 | -11,000 | -6,000 | -6,000 | -26,000 | -9,000 | 39,000 | 38,000 |
Earnings Before Taxes | -116.4% | -23,421,000 | -10,824,000 | -12,901,000 | -20,785,000 | -18,773,000 | -18,901,000 | -17,851,000 | -17,389,000 | -16,377,000 | -17,790,000 | -11,628,000 | -5,569,000 | -8,088,000 | -5,720,000 | -4,293,000 | -4,546,000 | -2,105,000 |
EBT Margin | -10.9% | -0.73 | -0.65 | -0.78 | -0.90 | -0.92 | -0.94 | -0.99 | -0.98 | -0.86 | -0.78 | -0.60 | -0.49 | - | - | - | - | - |
Net Income | -117.4% | -23,484,000 | -10,802,000 | -12,916,000 | -20,803,000 | -18,802,000 | -18,875,000 | -17,872,000 | -17,495,000 | -16,399,000 | -17,673,000 | -11,617,000 | -5,563,000 | -8,082,000 | -5,694,000 | -4,284,000 | -4,585,000 | -2,143,000 |
Net Income Margin | -10.9% | -0.73 | -0.66 | -0.78 | -0.90 | -0.92 | -0.94 | -0.99 | -0.98 | -0.86 | -0.78 | -0.60 | -0.49 | - | - | - | - | - |
Free Cashflow | -250.2% | -21,634,000 | -6,178,000 | -14,585,000 | -13,227,000 | -20,562,000 | -10,876,000 | -15,960,000 | -14,950,000 | -19,070,000 | -7,219,000 | -15,270,000 | -13,362,000 | - | - | - | - | - |
Balance Sheet | |||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Assets | -14.2% | 155 | 180 | 177 | 189 | 154 | 176 | 176 | 184 | 187 | 191 | 195 | 206 | 74.00 | 78.00 |
Current Assets | -16.4% | 102 | 122 | 117 | 126 | 92.00 | 112 | 112 | 120 | 126 | 141 | 146 | 157 | 24.00 | 29.00 |
Cash Equivalents | -83.5% | 14.00 | 83.00 | 79.00 | 93.00 | 60.00 | 74.00 | 52.00 | 47.00 | 94.00 | 113 | 120 | 136 | 12.00 | 18.00 |
Inventory | 28.6% | 23.00 | 18.00 | 19.00 | 16.00 | 15.00 | 14.00 | 13.00 | 13.00 | 11.00 | 9.00 | 6.00 | 7.00 | 5.00 | 4.00 |
Net PPE | -16.5% | 9.00 | 11.00 | 11.00 | 11.00 | 10.00 | 10.00 | 10.00 | 9.00 | 8.00 | 7.00 | 6.00 | 6.00 | 6.00 | 6.00 |
Goodwill | 0% | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 |
Liabilities | -3.6% | 122 | 127 | 115 | 117 | 112 | 117 | 101 | 93.00 | 81.00 | 70.00 | 58.00 | 59.00 | 64.00 | 60.00 |
Current Liabilities | -6.1% | 33.00 | 35.00 | 36.00 | 37.00 | 33.00 | 37.00 | 32.00 | 34.00 | 32.00 | 28.00 | 17.00 | 18.00 | 21.00 | 17.00 |
Long Term Debt | 0.3% | 75.00 | 75.00 | 64.00 | 64.00 | 63.00 | 63.00 | 53.00 | 43.00 | 33.00 | 32.00 | 32.00 | 32.00 | 33.00 | 33.00 |
LT Debt, Non Current | -100.0% | - | 75.00 | 64.00 | 64.00 | 63.00 | 63.00 | 53.00 | 43.00 | 33.00 | 32.00 | 32.00 | 32.00 | 33.00 | 33.00 |
Shareholder's Equity | -39.1% | 33.00 | 54.00 | 62.00 | 72.00 | 42.00 | 59.00 | 75.00 | 91.00 | 107 | 121 | 137 | 148 | - | - |
Retained Earnings | -10.2% | -253 | -230 | -219 | -206 | -185 | -166 | -147 | -130 | -112 | -96.11 | -78.43 | -66.82 | -61.25 | -52.28 |
Additional Paid-In Capital | 0.9% | 286 | 284 | 281 | 278 | 228 | 225 | 223 | 221 | 219 | 217 | 216 | 215 | - | - |
Shares Outstanding | 0.5% | 49.00 | 49.00 | 49.00 | 49.00 | 38.00 | 38.00 | 38.00 | 38.00 | 37.00 | 37.00 | 23.00 | 16.00 | - | - |
Float | - | - | - | - | 186 | - | - | - | 222 | - | - | - | 320 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 |
Cashflow From Operations | -272.9% | -20,824 | -5,584 | -13,753 | -11,804 | -19,758 | -10,007 | -12,171 | -13,386 | -17,932 | -5,854 | -13,395 | -12,415 | -4,404 | -2,147 | -1,740 | -1,999 | -957 |
Share Based Compensation | 0.1% | 2,566 | 2,564 | 2,878 | 2,620 | 2,375 | 2,120 | 2,044 | 1,721 | 1,545 | 1,411 | 1,158 | 1,216 | 254 | 54.00 | 60.00 | 51.00 | 312 |
Cashflow From Investing | -8118.4% | -48,817 | -594 | -832 | -1,423 | 6,196 | 22,131 | 7,266 | -42,338 | -1,138 | -1,365 | -1,875 | -947 | -907 | 9,653 | -902 | -588 | -1,435 |
Cashflow From Financing | -104.0% | -444 | 11,077 | -141 | 46,327 | -419 | 10,270 | 9,860 | 8,667 | -71.00 | 149 | -44.00 | 136,934 | -4.00 | 5,687 | 40.00 | 2,419 | -2,660 |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue | $ 18,350 | $ 21,410 |
Cost of goods sold | 9,971 | 9,117 |
Gross profit | 8,379 | 12,293 |
Operating expenses: | ||
Selling, general and administrative | 19,863 | 23,124 |
Research and development | 5,554 | 6,378 |
Change in fair value of contingent consideration | 179 | 227 |
Impairment | 2,971 | 0 |
Restructuring | 1,397 | |
Total operating expenses | 29,964 | 29,729 |
Loss from operations | (21,585) | (17,436) |
Other income (expense): | ||
Interest expense | (2,612) | (2,054) |
Interest income | 937 | 765 |
Other expense, net | (161) | (48) |
Loss before provision for income taxes | (23,421) | (18,773) |
Provision for income taxes | (63) | (29) |
Net loss | $ (23,484) | $ (18,802) |
Net loss per share attributable to common stockholders, basic | $ (0.48) | $ (0.49) |
Net loss per share attributable to common stockholders, diluted | $ (0.48) | $ (0.49) |
Weighted-average shares outstanding, basic | 49,188,170 | 38,326,024 |
Weighted-average shares outstanding, diluted | 49,188,170 | 38,326,024 |
Product | ||
Revenue | $ 12,140 | $ 15,524 |
Cost of goods sold | 6,723 | 5,751 |
Service and other | ||
Revenue | 6,210 | 5,886 |
Cost of goods sold | $ 3,248 | $ 3,366 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 13,039 | $ 83,125 |
Marketable securities | 48,536 | |
Accounts receivable, net | 13,473 | 16,994 |
Inventories, net | 22,988 | 17,877 |
Prepaid expenses and other current assets | 3,793 | 3,794 |
Total current assets | 101,829 | 121,790 |
Property and equipment, net | 8,964 | 10,729 |
Restricted cash | 700 | 699 |
Demo inventory, net | 726 | 893 |
Intangible assets, net | 16,699 | 17,412 |
Goodwill | 18,262 | 18,262 |
Operating lease right of use assets, net | 5,568 | 8,365 |
Financing lease right of use assets, net | 1,348 | 1,562 |
Other assets | 654 | 657 |
Total assets | 154,750 | 180,369 |
Current liabilities | ||
Accounts payable | 10,747 | 11,776 |
Accrued expenses and other current liabilities | 12,462 | 13,433 |
Current portion of operating lease liabilities | 2,654 | 2,681 |
Current portion of financing lease liabilities | 718 | 767 |
Deferred revenue | 6,612 | 6,688 |
Total current liabilities | 33,193 | 35,345 |
Deferred revenue, net of current portion | 2,928 | 3,193 |
Long-term debt, net of debt discount | 75,469 | 75,254 |
Deferred tax liability, net | 75 | 38 |
Operating lease liabilities, net of current portion | 5,713 | 6,238 |
Financing lease liabilities, net of current portion | 634 | 766 |
Contingent consideration liability, net of current portion | 4,015 | 5,765 |
Total liabilities | 122,027 | 126,599 |
Stockholders' equity: | ||
Preferred Stock, $0.00001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | ||
Common Stock, $0.00001 par value; 500,000,000 shares authorized at March 31, 2024 and December 31, 2023; 49,340,417 and 49,117,738 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 2 | 2 |
Additional paid in capital | 286,292 | 283,839 |
Accumulated deficit | (253,555) | (230,071) |
Accumulated other comprehensive loss | (16) | |
Total stockholders' equity | 32,723 | 53,770 |
Total liabilities and stockholders' equity | $ 154,750 | $ 180,369 |